Fixed-Dose Combination Cream for Plaque Psoriasis
The fixed-dose combination of calcipotriene 0.005% and betamethasone dipropionate 0.064% is strongly recommended for treating active plaque psoriasis, applied once or twice daily as a thin layer rubbed in gently and completely. 1, 2
Recommended Formulations and Application
The combination product is available in multiple formulations (cream, ointment, gel, foam), with the specific formulation choice depending on the treatment site:
- Body/trunk psoriasis: Apply cream or ointment once or twice daily 1, 2
- Scalp psoriasis: Use gel or foam formulation for 4-12 weeks 1
- Facial psoriasis: Consider calcipotriene combined with hydrocortisone (lower potency steroid) for 8 weeks 1
Evidence Supporting This Recommendation
The 2021 Joint AAD-NPF Guidelines provide Grade A evidence (strongest recommendation) for combination calcipotriene/betamethasone products 1. The landmark 52-week study demonstrated that 69-74% of patients achieved clear or almost clear skin compared to only 27% with vehicle control (P < .001) 1. Critically, no serious adverse events occurred, including no striae formation or hypothalamic-pituitary-adrenal axis suppression over the entire 52-week period 1.
Treatment Duration and Protocols
The combination can be used safely for up to 52 weeks, which is exceptional for a topical corticosteroid-containing product 1. This extended safety profile makes it suitable for:
- Acute treatment: Once or twice daily until clear/almost clear
- Long-term maintenance: Can continue up to 52 weeks
- Adjunctive therapy: Combine with systemic/biologic treatments for residual lesions 3, 4
Alternative dosing schedules for maintenance include:
- Vitamin D analogue twice daily on weekdays + high-potency corticosteroid twice daily on weekends 1
- Morning corticosteroid + evening vitamin D analogue 1
Critical Clinical Considerations
Avoid simultaneous use with salicylic acid - the acidic pH inactivates calcipotriene and reduces effectiveness 1
Phototherapy timing: If combining with phototherapy, apply the cream AFTER the UV treatment to prevent:
- UVA-induced degradation of calcipotriene
- Thick cream layers blocking UVB penetration 1
Why This Combination Works
The combination is more effective than either agent alone 1. While ultrapotent/potent corticosteroids alone outperform calcipotriene monotherapy at 3-8 weeks, the combination of calcipotriene with betamethasone dipropionate demonstrates superior efficacy compared to betamethasone monotherapy 1. The vitamin D analogue (calcipotriene) inhibits keratinocyte proliferation and enhances differentiation, while the corticosteroid provides anti-inflammatory effects 1.
Practical Advantages
The cream formulation using PAD (polyaphron dispersion) technology offers improved cosmetic characteristics that enhance patient adherence - a critical factor for treatment success 3, 4. Real-world evidence confirms effectiveness in difficult-to-treat areas including scalp, pretibial regions, and palmoplantar surfaces 4.